Researchers have developed a new therapy that can be injected intravenously right after a heart attack to promote healing and ...

RNA-based technologies are a powerful molecular biology toolbox, empowering scientists to decipher the complexities of living ...

Scientists have developed a powerful new injectable treatment that, when administered after a heart attack, helps the heart ...

Autologous mononuclear cells showed substantial activity in patients with advanced heart failure — and even though the study ...

The protein-like polymer, or PLP, platform is made from a polymer that mimics Nrf2. Once injected intravenously, it finds ...

In a transformative review, small noncoding RNAs (sncRNAs) have emerged as pivotal regulators in the complex landscape of ...

In the field of cardiology, University of Osaka Professor Sawa Yoshiki created the world’s first myocardial sheets using iPS cells, which he transplanted into the hearts of patients suffering from a ...

In a transformative review, small noncoding RNAs (sncRNAs) have emerged as pivotal regulators in the complex landscape of cardiovascular diseases.

The molecular mechanism behind why heart attacks can vary in severity depending on the time of day has been uncovered by ...

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.

Lexeo Therapeutics, Inc.’s LXEO share price has surged by 9.50%, which has investors questioning if this is right time to ...